With easily accessible and operator-friendly reagents,
shelf-stable ortho-methoxycarbonylethynylphenyl thioglycosides
were efficiently
prepared. Based on these MCEPT glycoside donors, a novel glycosylation
protocol featuring mild and catalytic promotion conditions with Au(I)
or Cu(II) complexes, expanded substrate scope encompassing challenging
donors and acceptors and clinically used pharmaceuticals, and versatility
in various strategies for highly efficient synthesis of glycosides
has been established. The practicality of the MCEPT glycosylation
protocol was fully exhibited by highly efficient and scalable synthesis
of surface polysaccharide subunits of Acinetobacter
baumannii via latent–active, reagent-controlled
divergent orthogonal one-pot and orthogonal one-pot strategies. The
underlying reaction mechanism was investigated systematically through
control reactions, leading to the isolation and characterization of
the vital catalyst species in MCEPT glycosylation, the benzothiophen-3-yl-gold(I)
complex. Based on the results obtained both from control reactions
and from studies leading to the glycosylation protocol establishment,
an operative mechanism was proposed and the effect of the vital catalyst
species reactivity on the results of metal-catalyzed alkyne-containing
donor-involved glycosylation was disclosed. Moreover, the mechanism
for C-glycosylation side product formation from ortho-(substituted)ethynylphenyl thioglycoside donors with
electron-donating substituents was also illuminated.